• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA APHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA APHERESIS SYSTEM Back to Search Results
Model Number 000000000000061000
Device Problems Incorrect Or Inadequate Test Results (2456); High Test Results (2457)
Patient Problem Seizures (2063)
Event Date 01/28/2014
Event Type  Injury  
Event Description
The customer reported that an operator may have entered the incorrect replacement hematocrit (hct) as 28% instead of 58% during a red blood cell exchange (rbcx) procedure.Approximately 40 minutes after the procedure, the patient developed seizures and was transported to intensive care unit with sedation and intubation.After the procedure, the patient's hematocrit was elevated from 28% to 48%, and the hemaglobin level increased to 16.5 g/dl.A physician performed multiple manual venesection and lowered the patient's hemaglobin to 9.2 g/dl.The customer declined to provide patient's age.The disposable set is unavailable for return because the customer discarded it.This report is being filed due to medical intervention via hospitalization, sedation, intubation, and manual venesection.
 
Manufacturer Narrative
Investigation evaluation and corrective actions are in-process.A follow-up report will be provided.
 
Manufacturer Narrative
There was no on-site service associated with this record, as the customer indicated that the problem resulted from incorrect data entry.No machine problem was alleged or suspected.The machine has been in use with no further occurrences of the problem.A review of the last year of service history for this device indicated no other reports related to this issue.The run data file (rdf) was reviewed for this event.Per the rdf, the replacement hct was entered at 30% and according to the customer, the actual replacement hct was 58%.If the replacement hct was entered with this much error it would explain why the patients end hct was 48% instead of 28%.Entry of incorrect values will result in incorrect end targets.The outcome of the procedure depends on the accuracy of the data entered.Root cause: the root cause of the reported problem was incorrect entry of the hematocrit for the replacement red cells by the operator.A report of operator error issues is distributed each quarter to sales and implementation for potential targeted training.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdr's, per fda request, to identify records in which a serious injury or medical intervention occurred, but the type of reportable event was not indicated as a serious injury of the mdr form.This supplement is being filed to modify information per fda request.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA APHERESIS SYSTEM
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10811 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key3645468
MDR Text Key4287750
Report Number1722028-2014-00065
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeGB
PMA/PMN Number
BK120012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,foreign,health professi
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 01/29/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number000000000000061000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/25/2014
Initial Date FDA Received02/25/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received03/25/2014
02/03/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/17/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Weight61
-
-